Recurrent and chronic rejection and infection are the principal reasons for poor outcomes in lung transplant recipients who manifest chronic lung allograft dysfunction (CLAD). The aetiology of CLAD is poorly understood and the prognosis is poor [1]. Indeed, environmental factors, including those from work, indoor sources and ambient sources (outdoors) that affect air quality, can be reasonably anticipated to affect the highly susceptible transplanted lungs as much as or more than healthy or diseased native lungs. Hence, there is an interest in studying whether environmental factors influence both the development and progression of post-transplantation complications including CLAD.The population of lung transplant recipients is diverse, with different underlying diseases, degrees of immune activation and immunosuppression, underlying genetic predisposing factors, comorbid conditions, and microbiological milieu that influence long-term survival and quality of life. Environmental factors, many of which can be investigated and remedied, can include indoor and outdoor air quality as well as biological factors or chemical hazards. Since air pollutants have been shown to have adverse effects on native lungs [2][3][4][5], it is entirely plausible that these factors can influence long-term success of allograft lungs. Attention to such factors may provide meaningful nonpharmacological approaches to improving outcomes. Two articles [6,7] in this issue of the European Respiratory Journal assess the association between ambient air pollution exposures and prognosis following lung transplantation. Taken together, these papers support the hypothesis that living in areas with higher outdoor concentrations of particulate matter air pollution and of traffic-related air pollutants lead to worse outcomes in lung transplant recipients.In an analysis from the Systems Prediction of Chronic Allograft Dysfunction (SysCLAD) study, SIROUX et al.[6] took advantage of serial lung function studies of 520 lung transplant recipients and found that higher air pollutant levels estimated at the homes of transplant recipients ( particulate matter and nitrogen dioxide) were associated with lower vital capacities. RUTTENS et al. [7] analysed CLAD mortality in 5707 patients from 13 European transplant centres, and found increased risk with higher residential estimated particulate matter concentrations and with living near major roads. Interestingly, both showed decreased risk for these effects among the group of transplant recipients taking macrolides. These findings suggest